0
Biologics Manufacturing Facilities To Access
0
Contract Manufacturing Organizations to Access
0
Key Parameters
0
Countries Covered
Tracker Highlights
left
right
comprehensive information

Competitive Assessment

This tracker provides an in-depth overview of the APAC Biologics CMOs and their manufacturing capabilities. Through this tracker IMAPAC aims to assist organizations to keep track of CMOs in the APAC region, identify any opportunities for strategic partnership or investments to speed biologics product to market.

Explore More, Request A Demoright

Key Parameters

Manufacturer's name, location, service offering capabilities, scale of manufacturing, technology platforms, products and sub-products manufactured, current & completed projects of CMOs, facility name, location, establishment year, facility size & capacity, annual production, batch size, bioprocessing equipment, bioreactors, expression system, manufacturing process type, regulatory compliance & certifications, sponsors & collaborations, expansions plans of CMOs and other parameters.

Explore More, Request A Demoright

Countries Covered

China (39%), India (15%), South Korea (11%), Taiwan (9%), Japan (8%), Singapore (5%), Australia (5%), Malaysia (4%), Thailand (2%), Hong Kong (1%), Indonesia (1%)

Explore More, Request A Demoright

Key Companies Covered

Serum Institute of Technology, Cell Therapies Pty Ltd, CMAB Biopharma, Lonza, Samsung Biologics, United Biopharma, Wuxi Biologics among other key CMOs

Explore More, Request A Demoright
bag